UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 50 filers reported holding UNIQURE NV in Q3 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $406,000 | -55.9% | 14,074 | -44.4% | 0.03% | -51.5% |
| Q3 2018 | $921,000 | +324.4% | 25,299 | +128.7% | 0.07% | +257.9% |
| Q4 2017 | $217,000 | -7.3% | 11,061 | -54.6% | 0.02% | -20.8% |
| Q3 2017 | $234,000 | -0.8% | 24,390 | -35.9% | 0.02% | -11.1% |
| Q2 2017 | $236,000 | -30.8% | 38,053 | -36.2% | 0.03% | -18.2% |
| Q1 2017 | $341,000 | +181.8% | 59,627 | +176.4% | 0.03% | +94.1% |
| Q4 2016 | $121,000 | -26.7% | 21,574 | 0.0% | 0.02% | -22.7% |
| Q3 2016 | $165,000 | -85.1% | 21,574 | -85.7% | 0.02% | -85.0% |
| Q2 2016 | $1,110,000 | -39.4% | 150,568 | -2.3% | 0.15% | -33.5% |
| Q1 2016 | $1,831,000 | +190.2% | 154,100 | +304.2% | 0.22% | +179.7% |
| Q4 2015 | $631,000 | – | 38,125 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |